IRWD
IRONWOOD PHARMACEUTICALS INC · Healthcare · Market cap $674.2M
Insiders sold $659K net in the last 90 days ·2 sellers, 0 buyers· 2 of 2 sales under Rule 10b5-1 plans· latest Form 4 filed Jul 9, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$22.6M
reported sales (SEC code S)
Unique Insiders
8
in the rolling window
Latest filing
Jul 22, 2026
Silver Ronald
IRONWOOD PHARMACEUTICALS INC (IRWD) has 27 SEC Form 4 filings (37 transaction rows) in the rolling window, disclosed by 8 distinct insiders. Most recent filing: Jul 22, 2026.
Inside the rolling window, 8 insiders at IRONWOOD PHARMACEUTICALS INC reported no open-market purchases and 17 open-market sales totaling $22.6M. The most active filer is PFO & PAO Silver Ronald with 4 filings. Insiders have net sold $22.4M over the trailing 6 months. The most recent open-market filing is a sale of 127,890 shares by PFO & PAO Silver Ronald, dated Jul 7, 2026, worth $578K.
- Industry:Drug Manufacturers - Specialty & Generic
- CEO:Thomas A. McCourt
- Employees:100
- HQ:Boston, MA, US
- IPO:2010-02-03
| Source | |||||||
|---|---|---|---|---|---|---|---|
Silver RonaldFirst in 4 months | PFO & PAO | Sale | 127,890 | $578K | Jul 9 | -12.6% | SEC ↗ |
McHugh JulieFirst filing | Director | Sale | 21,571 | $80K | Jun 17 | +15.9% | SEC ↗ |
DENNER ALEXANDER JFirst filing | Director | Sale | 6,730,800 | $20.5M | Mar 17 | +25.5% | SEC ↗ |
John MinardoFirst filing | Chief Legal Officer | Sale | 17,439 | $66K | Feb 25 | +21.4% | SEC ↗ |
John MinardoFirst filing | Chief Legal Officer | Sale | 19,053 | $70K | Feb 25 | +21.4% | SEC ↗ |
MCCOURT Thomas AFirst filing | Chief Executive Officer | Sale | 94,757 | $361K | Feb 25 | +21.4% | SEC ↗ |
MCCOURT Thomas AFirst filing | Chief Executive Officer | Sale | 103,526 | $379K | Feb 25 | +21.4% | SEC ↗ |
Martini Gregory S.First filing | Chief Financial Officer | Sale | 10,487 | $40K | Feb 25 | +21.4% | SEC ↗ |
Martini Gregory S.First filing | Chief Financial Officer | Sale | 11,457 | $42K | Feb 25 | +21.4% | SEC ↗ |
Shetzline MichaelFirst filing | SVP, CMO, Head-Res&Drug | Sale | 15,570 | $59K | Feb 25 | — | SEC ↗ |
Shetzline MichaelFirst filing | SVP, CMO, Head-Res&Drug | Sale | 17,012 | $62K | Feb 25 | — | SEC ↗ |
Gaskins Tammi LFirst in 3 months | Chief Commercial Officer | Sale | 10,287 | $39K | Feb 25 | — | SEC ↗ |
Gaskins Tammi LFirst in 3 months | Chief Commercial Officer | Sale | 11,239 | $41K | Feb 25 | — | SEC ↗ |
| Principal Accounting Officer | Sale | 11,552 | $44K | Feb 25 | — | SEC ↗ | |
| Principal Accounting Officer | Sale | 12,621 | $46K | Feb 25 | — | SEC ↗ | |
Silver RonaldFirst filing | Principal Accounting Officer | Sale | 35,416 | $163K | Jan 7 | — | SEC ↗ |
Gaskins Tammi LFirst filing | Chief Commercial Officer | Sale | 6,016 | $20K | Nov 19 | — | SEC ↗ |
Frequently asked questions
How many SEC Form 4 insider filings does IRWD have?
IRONWOOD PHARMACEUTICALS INC (IRWD) has 27 SEC Form 4 filings (37 transaction rows) in the rolling 365-day window, disclosed by 8 distinct insiders. Most recent filing: Jul 22, 2026.
When was the most recent SEC Form 4 filing for IRWD?
The most recent Form 4 filing for IRWD on Tracefour is dated Jul 22, 2026.
Who is the most active insider at IRWD?
The most active SEC Form 4 filer at IRWD in the rolling window is PFO & PAO Silver Ronald, with 4 filings.
What is the net insider flow at IRWD over the last 6 months?
Over the trailing 180 days, insiders at IRWD have net sold $22.4M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at IRWD in the current window?
Inside the rolling window, insiders at IRWD bought $0 and sold $22.6M based on SEC Form 4 filings.
Can I get alerts for IRWD insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at IRONWOOD PHARMACEUTICALS INC (IRWD). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
IRONWOOD PHARMACEUTICALS INC is in the Healthcare sector.